cancer inhibitors trang 7 tải miễn phí từ TAILIEUCHUNG

"cancer inhibitors" trang 7 - tải miễn phí từ Tailieuchung

Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptortyrosine kinase inhibitors for non-small cell lung cancer

Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptortyrosine kinase inhibitors for non-small cell lung cancer

9 74 0

EGFR mutation testing and treatment decisions in patients progressing on firstor second-generation epidermal growth factor receptor tyrosine kinase inhibitors

EGFR mutation testing and treatment decisions in patients progressing on firstor second-generation epidermal growth factor receptor tyrosine kinase inhibitors

13 79 0

Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

5 64 0

The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: A retrospective study

The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: A retrospective study

13 51 0

Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: A case report

Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: A case report

6 39 0

Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro

Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro

11 33 1

Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

10 66 1

Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study

Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study

8 38 1

Crosslink between Temozolomide and PDL1 immune-checkpoint inhibition in glioblastoma multiforme

Crosslink between Temozolomide and PDL1 immune-checkpoint inhibition in glioblastoma multiforme

7 76 1

Immunotherapy and associated immunerelated adverse events at a large UK centre: A mixed methods study

Immunotherapy and associated immunerelated adverse events at a large UK centre: A mixed methods study

11 68 1

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormonesensitive breast cancer

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormonesensitive breast cancer

11 20 1

Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5- azanucleosides and topoisomerase inhibitors

Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5- azanucleosides and topoisomerase inhibitors

13 26 1

IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis

IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis

16 20 1

Case report: Small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors

Case report: Small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors

6 35 1

Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset

Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset

10 28 1

Safety and efficacy of vemurafenib in end stage renal failure

Safety and efficacy of vemurafenib in end stage renal failure

4 29 1

VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma

VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma

7 33 1

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

9 25 1

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents

5 34 1

RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer

RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer

23 20 1

Đầu
1
2
3
4
5
6
[ 7 ]
8
9
10
11
12
13
14
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.